SEC Filings

Filing date	Form	Description	View
Nov 6, 2013	DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	View HTML 0000950123-13-008440.pdf 0000950123-13-008440.xls
May 9, 2008	REGDEX	REGDEX	View HTML
Dec 18, 2006	REGDEX	REGDEX	View HTML
Jun 16, 2006	REGDEX	REGDEX	View HTML

Data provided by Kaleidoscope.

Day High:
Day Low:
Volume:

IR Contact

Justine E. Koenigsberg
Senior Vice President,
Corporate Communications
and Investor Relations
781.674.5284
ir@concertpharma.com

Printed Materials

Email Alerts

RSS